Executives to host one-on-one and small group meetings
IRVINE, Calif., Nov. 26, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today announced it has been invited to present at the following two investor conferences in December.
11th Annual LD Micro Main Event
Tuesday, December 4, 2018 at 11:00 a.m. PT (formal presentation and one-on-one meetings)
13th Annual Singular Research 'Best of the Uncovered' – Small Cap
Thursday, December 13, 2018 (formal presentation and one-on-one meetings)
BIOLASE President and CEO Todd Norbe and Executive Vice President and CFO John Beaver will present and/or host one-on-one and small group meetings with institutional investors at these conferences. Meetings can be scheduled through the firms hosting the conferences or through BIOLASE's investor relations firm, EVC Group LLC (contact information below).
To access the live webcast or replay of the formal presentation at the LD Micro conference, visit the investor relations section of the company's website at www.biolase.com.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. We are investors, first and foremost. What started out as a newsletter highlighting unique companies has transformed into several influential conferences annually (Invitational, Summit, and Main Event). In 2015, LD Micro launched ldmicro.com as a portal to provide exclusive intraday information on the entire sector, including the first pure microcap index (LDMi) which covers stocks in North America with market capitalizations between $50-$300 million.
About Singular Research
Singular Research aims to be the most trusted supplier of independent, trusted, single-source research on small-to-micro cap companies to the small-to-medium sized Hedge Fund manager. We will provide quarterly updates for 40 to 70 companies and make recommendations. How do we strive to achieve our Mission / Goal?
- Find under or overvalued securities: Our goal is to provide initiation reports and quarterly updates for approximately 40 micro to small cap companies. In most cases, our analysts research companies that are not covered by any other firms.
- We provide Honest Advice: Our Independent analysts have no financial interest in the stocks we cover. Analysts are compensated based on the accuracy of their research calls not through trading commissions or potential deal flow.
- Track Record: Our picks have gained 299.3% since inception in 2004, compared with a gain of 116.4% for the Russell 2000 and 77.8% for the S&P 500 over the same period.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 327 patented and 69 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold over 38,100 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer markets.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-announces-schedule-of-investor-conferences-in-december-300755046.html